Asia Pacific Plastic Surgery
Shim Ching, MD
• The Best Doctors in America, 2011 - present
• Allergan’s Top 100 Plastic Surgery Practices in the US, 2019 - present
• Honolulu Magazine’s Top Doctors in Hawaii, 2015 - present





At Asia Pacific Plastic Surgery, we offer Semaglutide, a weight loss injectable in Honolulu, HI, to our patients as part of a comprehensive weight loss protocol. Semaglutide aids the weight loss process by making patients feel full faster, reducing the incidence of overeating, and enabling them to make it through the day without feeling excessively hungry.
Semaglutide first received approval for the treatment of Type 2 diabetes in 2017. It is considered to be highly effective in stabilizing glycemic levels. The treatment is designed to increase insulin levels while causing a reduction in glucagon secretion, which aids in stabilizing blood sugar levels. Similar to other brands like Wegovy, Ozempic, and Mounjaro, Semaglutide is able to reduce appetite, mitigate food cravings, and promote glycemic balance in the body. While Semaglutide can achieve incredible results on its own, it is most beneficial when used in tandem with a healthy diet and exercise regimen.
Semaglutide matches GLP-1 (glucagon-like peptide-1), a hormone in the body that is designed to manage the patient’s appetite. Semaglutide optimizes this peptide hormone, resulting in feelings of satiety after eating smaller portions of food than the patient’s normal intake.
Semaglutide also interacts with the pancreas, inducing it to release a measured amount of insulin in the event that blood sugar levels rise to a higher-than-normal level. It also causes a slowing of the passage of food through the stomach, resulting in decreased appetite levels. This process is known as gastric emptying.
Unfortunately, insurance is not accepted to pay for Semaglutide injections. Dr. Ching understands the importance of getting access to Semaglutide now rather than later, however, and offers financing for patients via reputable healthcare lenders such as CareCredit and PatientFi. Pricing for Semaglutide can be discussed in more depth during your private consultation.
*Individual results may vary
Semaglutide is a prescription medication that can only be acquired through a licensed weight loss practitioner. It is important to note that not all patients will be considered eligible for the treatment. In order to qualify for Semaglutide, patients must be at a BMI of 30 or above. That said, patients who are dealing with obesity-related conditions such as hypertension, Type 2 diabetes, or high cholesterol may still be eligible for treatment with Semaglutide, provided that their BMI is at least 27.
During the private consultation, we review the patient’s medical history and current status to determine whether they are suitable candidates for Semaglutide. Individuals who have a history of tumors or cancer are typically not considered to be good candidates. All information regarding current medications must be disclosed during the consultation.
Since our inception, Asia Pacific Plastic Surgery has been dedicated to providing our patients throughout the Pacific, Asia, and the Middle East with some of the most cutting-edge and innovative treatments available.
Headed by the highly revered and board-certified Dr. Shim Ching, our team has a great wealth of experience and expertise which they use in prescribing and managing Semaglutide, helping patients achieve their desired weight loss goals. We carry out a full review of our patients’ medical and family histories and keep an eye on their progress throughout the treatment.
Reach out to us today to schedule a private consultation and learn more about Semaglutide injections.
© Shim Ching MD. All Rights Reserved. Web Design & Internet Marketing by Studio III